Description

Description

Erli 10mg is a prescription-based oral medication manufactured by PharmaEvo, containing Empagliflozin as its active ingredient. Each pack contains 14 tablets designed to support the management of type 2 diabetes mellitus in adults. Empagliflozin belongs to a class of medicines known as SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors), which work by helping the kidneys remove excess glucose from the bloodstream through urine, rather than allowing it to be reabsorbed back into circulation. This mechanism offers a distinct approach to blood sugar regulation compared to other antidiabetic drug classes, and it is often prescribed either as a standalone therapy or in combination with other diabetes medications, depending on a physician’s assessment. Erli is intended to be used as part of a broader treatment plan that typically includes a balanced diet, regular physical activity, and routine blood glucose monitoring. It is not a substitute for insulin in patients who require it, nor is it intended for use in type 1 diabetes.

Ingredients

The primary active ingredient in Erli 10mg tablets is Empagliflozin, present in a strength of 10mg per tablet. The formulation may also include standard pharmaceutical excipients such as binders, fillers, and coating agents that help maintain tablet stability, appearance, and ease of swallowing. These inactive components do not contribute to the therapeutic action of the medicine but are essential for proper tablet formation and shelf stability.

Dosage Form

Erli is available in the form of oral film-coated tablets, each containing 10mg of Empagliflozin. The pack includes 14 tablets, offering a convenient supply for short-term prescription cycles or as directed by a healthcare provider.

Uses

Erli 10mg is primarily used to help improve blood sugar control in adults diagnosed with type 2 diabetes mellitus. It may be prescribed alone or alongside other antidiabetic medicines such as metformin, sulfonylureas, or insulin, based on individual patient needs. In some cases, Empagliflozin-based medicines are also used to help reduce the risk of certain cardiovascular complications in diabetic patients with existing heart-related risk factors, as determined by a treating physician. It should only be used for the condition it has been prescribed for and under continuous medical supervision.

How to Use

Erli tablets are generally taken once daily, preferably in the morning, with or without food, unless otherwise directed by a doctor. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed unless specifically instructed. Dosage and duration of treatment should strictly follow the prescribing physician’s instructions, as individual requirements may vary based on kidney function, other medications being taken, and overall health status. Missing a dose should not be compensated with a double dose; instead, the next dose should be taken at the regular scheduled time.

Side Effects

As with most medications, Erli may cause side effects in some individuals, though not everyone experiences them. Commonly reported effects include urinary tract infections, genital yeast infections, increased urination, thirst, and mild dehydration. Less commonly, some patients may experience low blood pressure, dizziness upon standing, or changes in kidney function markers. In rare cases, more serious effects such as ketoacidosis (even with normal blood sugar levels) have been reported and require immediate medical attention if symptoms like nausea, vomiting, abdominal pain, or unusual fatigue occur. Any unusual or persistent symptoms should be reported to a healthcare provider promptly.

Pregnancy & Breastfeeding

Erli is generally not recommended for use during pregnancy, as SGLT2 inhibitors like Empagliflozin may pose risks to fetal development, particularly during the second and third trimesters. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor immediately. Similarly, it is not advised for use during breastfeeding, as it is not fully established whether the medication passes into breast milk and what effects it may have on a nursing infant. Alternative treatment options are typically considered for diabetic patients during these periods, and any changes to medication should only be made under medical guidance.

Storage Instructions

Erli tablets should be stored in a cool, dry place away from direct sunlight and moisture, ideally at room temperature. Keep the medicine in its original packaging until the time of use, and ensure it is stored out of reach of children and pets. Do not use the tablets beyond the expiry date printed on the pack, and dispose of any unused or expired medication safely according to local pharmaceutical disposal guidelines.

FAQs

Can Erli be taken with other diabetes medicines?
Yes, it is often prescribed alongside other antidiabetic medications, but only under medical supervision to avoid interactions or excessive blood sugar lowering.

Is Erli suitable for type 1 diabetes?
No, Erli is intended specifically for type 2 diabetes management and is not approved for type 1 diabetes.

What should I do if I miss a dose?
Skip the missed dose and continue with your next scheduled dose. Do not double the dose to make up for a missed one.

Can I stop taking Erli once my sugar levels normalize?
Treatment should never be stopped or altered without consulting your doctor, even if blood sugar levels appear to improve.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.